Richard Scheller

Insider Reports History

Entity
Individual
Location
C/O Genentech Inc, 1 Dna Way Ms 49, South San Francisco, CA
Signature
/s/ Richard Scheller, by Guy Chayoun, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Scheller:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Pharma, Inc. Director Common Stock 53.8K $2.04M $37.97 Feb 16, 2023 Direct
BridgeBio Pharma, Inc. Director Restricted Stock Units 12.8K $378K $29.55 Feb 16, 2023 Direct
Oric Pharmaceuticals, Inc. Director Common Stock 39.1K $336K $8.59 May 24, 2021 Direct
23andMe Holding Co. Director Class A Common Stock 896K $299K $0.33 Aug 26, 2024 Direct
Alector, Inc. Director Common Stock 35K $181K $5.16 Aug 22, 2024 Direct
DICE Therapeutics, Inc. Director Common Stock 0 $46.50 Aug 9, 2023 Direct
DICE Therapeutics, Inc. Director Stock Option (right to buy) 0 Aug 9, 2023 Direct

Insider Reports Filed by Richard Scheller

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ME 23andMe Holding Co. Aug 26, 2024 1 $0 4 Aug 28, 2024 Director
ALEC Alector, Inc. Aug 22, 2024 1 -$228K 4 Aug 23, 2024 Director
ALEC Alector, Inc. Aug 2, 2024 1 $0 4 Oct 10, 2024 Director
ALEC Alector, Inc. Jun 12, 2024 1 $0 4 Jun 12, 2024 Director
ME 23andMe Holding Co. Sep 6, 2023 1 $0 4 Sep 8, 2023 Director
DICE DICE Therapeutics, Inc. Aug 9, 2023 6 $0 4 Aug 9, 2023 Director
ALEC Alector, Inc. Jul 15, 2023 1 $0 4 Feb 14, 2024 Director
ALEC Alector, Inc. Jun 14, 2023 2 $0 4 Jun 15, 2023 Director
DICE DICE Therapeutics, Inc. May 5, 2023 1 -$3.24M 4 May 9, 2023 Director
BBIO BridgeBio Pharma, Inc. Feb 16, 2023 3 -$16.5K 4 Feb 21, 2023 Director
BBIO BridgeBio Pharma, Inc. Nov 16, 2022 3 -$10.7K 4 Nov 18, 2022 Director
ME 23andMe Holding Co. Nov 11, 2022 1 -$59.7K 4 Nov 14, 2022 Director
ME 23andMe Holding Co. Sep 6, 2022 1 $0 4 Sep 8, 2022 Director
ME 23andMe Holding Co. Aug 25, 2022 1 $0 4 Aug 29, 2022 Director
BBIO BridgeBio Pharma, Inc. Aug 16, 2022 3 -$12.2K 4 Aug 18, 2022 Director
BBIO BridgeBio Pharma, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
ALEC Alector, Inc. Jun 16, 2022 2 $0 4 Jun 21, 2022 Director
DICE DICE Therapeutics, Inc. Jun 7, 2022 1 $0 4 Jun 8, 2022 Director
BBIO BridgeBio Pharma, Inc. May 16, 2022 3 -$8.83K 4 May 18, 2022 Director
BBIO BridgeBio Pharma, Inc. Feb 28, 2022 1 $0 4 Mar 15, 2022 Director
BBIO BridgeBio Pharma, Inc. Dec 2, 2021 2 $0 4 Dec 6, 2021 Director
DICE DICE Therapeutics, Inc. Sep 14, 2021 6 $0 4 Sep 16, 2021 Director
ME 23andMe Holding Co. Sep 14, 2021 1 $0 4 Sep 16, 2021 Director
DICE DICE Therapeutics, Inc. Sep 14, 2021 0 $0 3 Sep 14, 2021 Director
BBIO BridgeBio Pharma, Inc. Aug 4, 2021 3 -$499K 4 Aug 6, 2021 Title: Chairman of Research and Development, Director
ALEC Alector, Inc. Jul 2, 2021 5 -$1.3M 4 Aug 9, 2021 Director
BBIO BridgeBio Pharma, Inc. Jun 17, 2021 1 $0 4 Jun 22, 2021 Chairman of R&D, Director
ALEC Alector, Inc. Jun 17, 2021 1 $0 4 Jun 22, 2021 Director
ME 23andMe Holding Co. Jun 16, 2021 0 $0 3 Jun 25, 2021 Director
ORIC Oric Pharmaceuticals, Inc. May 20, 2021 3 -$50K 4 May 24, 2021 Director
ORIC Oric Pharmaceuticals, Inc. May 14, 2021 3 -$201K 4 May 18, 2021 Director
ORIC Oric Pharmaceuticals, Inc. May 11, 2021 3 -$12.6K 4 May 13, 2021 Director